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Objective: The objective of this selective EBM review is to determine whether or not 
extracorporeal shock wave therapy is an effective treatment for improving pain in adults with 
medial tibial stress syndrome. 
 
Study Design: Systematic review of two randomized controlled trials (RCTs) and a cohort study 
published in peer-reviewed journals from 2010-2017, all in the English language.  
 
Data Sources: Two randomized controlled trials found through PubMed and a cohort study 
found through Google Scholar.  
 
Outcomes Measured: Pain was measured using a numerical rating scale (0-10) and visual 
analog scale (VAS). 
 
Results: Study by Newman et al. (J Sci Med Sport. 2017;20(3):220-224. doi: S1440-
2440(16)30140-2 [pii]) demonstrates pain improvement for bone pressure was only significant in 
the control group rather than the experimental group with a mean difference of 1.1 out of 10, 
95% CI 0.0-2.3, (p= 0.05); with no significance shown for muscle pressure or running. Study by 
Gomez et al. (Int J Surg. 2017;46:102-109. doi: S1743-9191(17)31244-X [pii]) showed clinical 
and statistical significance with an NNT value of 2, (p= 0.001), and mean change from baseline 
of 4.61. Finally, study by Rompe et al. (Am J Sports Med. 2010;38(1):125-
132. https://doi.org/10.1177/0363546509343804. doi: 10.1177/0363546509343804) showed pain 
improvement was statistically significant with (p <.001) and mean change from baseline of 5.4.  
 
Conclusions:  Evidence supporting the use of extracorporeal shock wave therapy for pain 
improvement in adults with MTSS was conflicting between the three articles studied in this 
systematic review. Two studies found this treatment statistically significant while one did not 
display any significance with shockwave therapy. 
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INTRODUCTION 
Medial tibial stress syndrome (MTSS), commonly known as shin splints, is an overuse 
injury that causes pain over the distal portion of the posteromedial tibia spreading over an area 
greater than 5cm. The pathophysiology of this condition is unclear, but it is believed to be due to 
microdamage in the cortical bone that is associated with periostitis overlying the distal tibia due 
to continuous muscle traction.1,2 The repetitive stress that the bone, connective tissue, and 
surrounding muscles undergo during high impact exercises causes significant and debilitating 
pain to the anterior portion of the shin.1,2  
MTSS is due to high impact exercises such as running and jumping and therefore, is 
popular in many athletes and military recruits due to the constant strenuous activities they 
perform on a daily basis. Currently, MTSS affects between 13.6% to 20% of runners and up to 
35% of military recruits with a prevalence of 9.5%.1,2 Additionally, Rompe et al. reports that 
MTSS contributes to 50% of all lower leg injuries.3 Of the 50%, 6% to 16% resulted from 
running.3 On the other hand, MTSS is not limited to this population alone. Adults diagnosed with 
prevalent conditions such as diabetes, CVD, and obesity who are encouraged to increase their 
physical activity for health benefits can be at risk as well.4,5 Any form of increased physical 
activity such as an increase in duration, frequency, and intensity can contribute to MTSS.4,5   
Diagnosis is made clinically with signs and symptoms of dull pain and tenderness to 
palpation of the distal tibia that is typically worse at the beginning and end of exercising.1,2 Pain 
is usually absent during exercise unless it is very severe.1,2 Since diagnosis for this condition is 
made clinically, healthcare visits are often required for diagnosis. The exact estimate for 
healthcare visits each year could not be identified. However, a systematic review by Yeung 
states, “12% to 44% of patients with lower leg soft tissue injuries require medical attention”.6 
This percentage of medical attention for MTSS also leads to significant healthcare cost. Yeung’s 
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review also states, lower leg soft tissue running injuries have a huge effect on morbidity and 
healthcare cost.6 It is important to properly diagnose and obtain professional healthcare for this 
condition. If left untreated it can progress to a stress fracture which will cause a tremendous 
elevation in medical attention, testing, and healthcare cost, leading to greater debilitation that 
could have been prevented.  
The mainstay of treatment for MTSS is activity modification with relative rest. Other 
conservative treatment methods such as ice, NSAIDS, stretching and strengthening, attention to 
biochemical factors, orthotics, and kinesiotaping have been shown to be somewhat effective in 
the treatment of MTSS.2,3,7 The problem with these forms of treatment is that it is all require 
moderate time before effects are realized. Presently, there is not an intervention that quickens the 
process of recovery or decreases treatment time. Other techniques attempted are cryotherapy, 
laser therapy, acupuncture, ultrasound, and corticosteroid injections.2,3,7 In severe refractory 
cases, surgery with a fasciotomy of the posterior superficial compartment of the leg can be 
considered.2,3,7 Currently, there is unclear evidence for the best management for MTSS with low 
quality evidence that many of the above treatments are effective. Prevention and treatment of this 
condition should be explored in further detail. Therefore, shockwave therapy should be studied as 
an alternative form of treatment to effectively improve pain caused by medial tibial stress 
syndrome. This systematic review will evaluate two randomized controlled trials and a cohort 
study comparing the efficacy of extracorporeal shock wave therapy for improving pain in adults 
with medial tibial stress syndrome.  
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not extracorporeal 
shock wave therapy is an effective treatment for improving pain in adults with MTSS.   
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METHOD 
 Two randomized controlled trials and a cohort study that consisted of adults with medial 
tibial stress syndrome were selected for this review. The interventions used in these studies was 
extracorporeal shock wave therapy and its comparisons were sham dose shockwave therapy, an 
exercise program, and a home training program. Newman et al. used a standard dose shockwave 
therapy that progressively increase each week from 0.1 to 0.3 mJ/mm2 at 1500 pulses while the 
control group received a sham dose of shockwave therapy, the lowest dose deliverable at 0.01 
mJ/mm2 at 1000 pulses in week 1 and 1500 pulses thereafter.8 Gomez et al. used a single session 
of 1500 pulses of 0.20 mJ/mm2 and frequency of 5 Hz combined with an exercise program of 40 
minutes of exercise 5 days a week, control group only used the exercise program.7 Rompe et al. 
used an intervention of 3 low-energy treatments in weekly intervals of 2000 shocks with 
0.1mJ/mm2 combined with a home training program while the control group only used the home 
training program.3 Outcomes measured were numerical rating scale and visual analog scale.  
 The studies were found in peer reviewed journals though PubMed and Google Scholar. 
The keywords used for this search were “shockwave” and “medial tibial stress syndrome”. 
Articles were selected based on if their material qualified to answer the clinical question being 
discussed and if the outcomes were relevant to or oriented to the patient (POEMS). These articles 
were published from 2010-2017. Inclusion criteria includes studies published after 2007, with 
male and female participants who were 18 years old or older who were experiencing pain to the 
posteromedial tibia with exercise. Exclusion criteria includes studies published in 2007 or earlier. 
The statistics reported in these studies were mean change from baseline, standard deviation, 
NNT, EER, CER, RBI, ABI, CI and p-values.   
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Table 1. Demographics and Characteristics of Included Studies 3,7,8 
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OUTCOMES MEASURED 
The patient-oriented outcome measured in these trials was pain improvement. This 
outcome was measured using the numerical rating scale (NRS) and visual analog scale (VAS). 
Newman et al. used the numerical rating scale which ranges from 0-10, with 10 being the worst 
pain imaginable and 0 being no pain at all.8 Pain was measured during bone and muscle pressure 
(5 kg of pressure applied) as well as during running (until pain level reached 4 out of 10).8 The 
results were compared from the control group and experimental group from week 1 to week 10.8 
Rompe et al.  also used the numerical rating scale to assess pain which was collected at baseline, 
1 month, 4 months, and 15 months.3 Gomez et al. used the visual analog scale (VAS), which 
recorded pain level on a scale from 0-10 during rest and at the end of running.7 Pain greater than 
or equal to 4 was considered moderate to high pain levels. These scores were recorded and 
compared over 4 weeks between the experimental group and the comparison. Mean change from 
baseline and p values were recorded to determine the effectiveness of the treatment groups 
compared to the control groups.  
RESULTS 
The double-blind randomized control trial by Newman et al. conducted a study on 28 
participants, 18 females and 10 males with a mean age of 34 years old.8 Of the 28 participants 4 
were lost to follow up.8  Participants were included in the study after being diagnosed with MTSS 
by clinical examination and consultation with a sports physiotherapist.8 Participants were 
randomly allocated into an experimental group and a control group with similar demographics at 
baseline. Allocation was concealed from the recruiter and participants. The experimental group 
received a standard dose shockwave therapy that progressed from 0.1 to 0.3 mJ/mm2 at 1000-
1500 pulses from week 1 to week 10 with a cumulative dose of 1450 mJ/mm2 divided in 5 
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sessions.8 The control group received the lowest shockwave dose possible of 0.01 mJ/mm2 at a 
1000-1500 pulses, with a cumulative dose of 70mJ/mm2 over 5 sessions.8 
The outcome of the study was to assess pain improvement with bone pressure, muscle 
pressure, and running at the end of the 10 weeks between the experimental group and the control 
group.8 This outcome was measured using the numerical rating scale and reported as mean 
change from baseline, standard deviation, and 95% CI. The mean change from baseline was only 
significant for bone pain which was 1.9 for the control and 0.6 for the experimental group.8  This 
illustrates bone pain improvement was greater in those receiving the sham dose shockwave 
therapy (control group) and was calculated to be statistically significant with a mean difference 
of 1.1 out of 10, 95% CI 0.0-2.3, and p value of 0.05.8 For muscle pain during running the mean 
change from baseline, standard deviation, and 95% CI was not significant when comparing the 
experimental group to the control group and is demonstrated in Table 2.8 
Table 2. Comparison of Intervention group and Control group at baseline and week 10 8 
 
Outcome Groups Difference between groups 
 Week 1 Week 10 Week 10 minus week 1 
Pain NRS  
(0-10) 
Exp 







Exp min Con 
Bone 
pressure 
5.9 (2.4) 5.5 (2.0) 5.3 (2.4) 3.6(1.7) 1.1 (0.00 to 2.3) 
Muscle 
pressure 
3.6 (2.5) 3.9 (1.8) 3.3 (1.6) 3.2 (1.8) 0.2 (-1.5 to 1.9) 
Running 6.9 (1.3) 6.6 (2.0) 3.2 (2.5) 2.9 (3.0) -0.1 (2.9 to -2.7) 
Mean (SD) of groups and mean (95% CI) difference between groups  
Gomez et al. conducted a single-blind randomized controlled study consisting of 42 
military cadets, 33 men and 9 women, at the Military School of Cadets of the Colombian Army.7 
These participants were diagnosed with MTSS and enrolled by the orthopedic surgeon who was 
blinded to the patient’s treatment allocation. The cadets were randomly assigned to the 
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experimental group who received a single session of 1500 pulses at 0.20 mJ/mm2 at 5 Hz 
frequency along with a specific exercise program or the control group who just received the 
exercise program which consisted of 40 minutes of exercise, five days a week for 4 weeks with a 
physiotherapist.7 Allocation was concealed from the recruiter and the participants. The control 
group also received cryotherapy after performing the exercises in attempt to mitigate the 
biological effects of ESWT.7 
The endpoint of the study was to assess if pain improvement at the end of running was 
greater in the experimental group versus the control group. Gomez et al. was able to dichotomize 
their data by using the visual analog scale for pain.7 Participants were classified as either having 
a high level of pain (VAS≥4) versus a low level of pain (VAS<4) at baseline and at the end of 
treatment which is displayed in Table 3.7 From the data in Table 3, NNT, EER, CER, RBI, and 
ABI were able to be calculated and are displayed in Table 4. The results confirmed to be 
clinically significant with an NNT value of 2.7 In addition, the experimental group showed 
statistical significance over the control group with p=0.001 and a mean change from baseline of 
4.61 compared to 3.05 for the control group.7 
Table 3. Comparison of Experimental and Control groups at baseline and 4 weeks.7 
Percent reduction of pain for both groups using VAS7 
Group & Variables Before treatment At the end of treatment 
 Frequency Percentage Frequency  Percentage 
 ESWT + Exercise 
VAS (end of running)     
High pain 23 100.0 7 30.4 
Low pain 0 0.0 16 69.6 
 Exercise 
High pain 19 100.0 17 89.5 
Low pain 0 0.0 2 10.5 
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Table 4. Comparison of Experimental and Control groups in Gomez et al.  
CER EER RBI ABI NNT 
0.11 0.70 0.84 0.59 2 
 
The cohort study conducted by Rompe et al. consisted of 94 subjects, 54 women and 40 
men, diagnosed with MTSS; who were divided into an experimental group and a control group 
with 10% being lost to follow up.3 There was no significant difference in sex, age, and symptom 
duration between the experimental group and the control group at baseline. Each group was 
treated with rest, ice, and rehabilitation exercises (calf stretching, Thera-Band strengthening, heel 
raises, toe raises) twice a day for 12 weeks.3 The experimental group was also given 3 
shockwave treatments of 2000 shocks at 0.1 mJ/mm2 at 2, 3, and 4 weeks.3  
The outcome of the study was to determine if pain improvement was significantly better 
for the experimental group compared to the control group using the numerical rating scale. Mean 
NRS score improved in the experimental group from 8.1 at baseline to 2.7 at the end of 15 
months, demonstrating a mean change from baseline of 5.4.3 The control group only 
demonstrated a mean change of 3.3 at the end of the 15 months.3 Furthermore, the between 
group difference for 1 month, 4 months, and 15 months was statistically significant with p<.001.3  
Table 5. Comparison of Experimental and Control groups at baseline, 1, 4, and 15 months3 
Mean NRS score and (mean change from baseline)3 
 Pretreatment 1 month 4 months 15 months 
Experimental 8.1 + 3.4 5.8+0.9 (2.3) 3.8+1.1 (4.3) 2.7+0.9 (5.4) 
Control 8.5+3.1 7.3+2.9 (1.2) 6.9+0.8 (1.6) 5.3+2.6 (3.2) 
Between-group 
difference (p-value) 
 P<.001 P<.001 P<.001 
 
DISCUSSION 
This systematic review evaluated two randomized control trials and a cohort study to 
illustrate the effectiveness of shockwave therapy for treating pain related to MTSS. Two of the 
three studies did show statistical improvement in pain with shockwave therapy. However, in the 
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double-blind randomized control trial by Newman et al. pain improvement for bone pressure was 
only significant in the control group (sham shockwave therapy) rather than the experimental 
group, with no significance shown for muscle pressure or running. Some explanations to this can 
be that the trial was only 10 weeks long and symptom duration for MTSS tends to be much 
longer, with most participants having experienced pain for an average of 30 months.8 Also, the 
participants in this study did not decrease their activity levels which is an important intervention 
used in treating MTSS.8 Another limitation is that the shockwave probe was directed towards the 
bone rather than the musculature which can be why pain improvement with bone was the only 
significant measure.8 Furthermore, the dose of shockwave therapy may be more beneficial at low 
doses which is why the sham dose may have shown improvement over the experimental group.8 
The main limitation to this trial is the small sample size of only 28 participants, this study is 
therefore not generalizable to patients with medial tibial stress syndrome and a larger sample size 
should assessed.8 
In the study conducted by Gomez et al. pain improvement with shockwave therapy 
showed to be clinically significant with NNT of 2 and statistically significant with a p value of 
0.001.7 One factor to consider in this study is the patients only received one dose of shockwave 
therapy where other studies obtained multiple. This suggests that shockwave therapy can be 
more beneficial at small doses or with just one dose. Some limitations to this study are the small 
sample size of 42 participants that focuses solely on Colombian military cadets and a short 
follow up of only 4 weeks.7 Another limitation is that cryotherapy was given to the control group 
as an alternative form of treatment that was not given to the experimental group.7 
The cohort study by Rompe et al. demonstrated pain improvement with shockwave 
therapy that was statistically significant with p<.001.3 Being that this was a cohort study, 
randomization was not in effect because the subjects chose their group. Also, a placebo arm was 
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not utilized.3 This study also used a daily at home training program which could raise suspicion 
to patient compliance.3 Another limitation to the study is that a prescription of pain medication 
was allowed at the 4th month follow up if needed.3  
 With each study having its own limitations, one that is present throughout is pain 
tolerance. In each of these studies pain is self-reported, and all patients experience different 
levels of pain tolerance which could skew the data.  
CONCLUSION 
 The two randomized control trials and one cohort study discussed in this systematic 
review showed conflicting evidence on whether or not extracorporeal shock wave therapy is an 
effective treatment for improving pain in adults with medial tibial stress syndrome. Two studies 
found this treatment statistically significant while one did not display any significant 
improvement with shockwave therapy. Further studies should consider testing for the best 
therapeutic treatment dose and frequency of administering shockwave therapy for pain 
improvement. They should also consider obtaining a larger sample size and a longer follow up 
period. Continuing studies on the use of shockwave therapy for pain improvement in adults with 
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